when fecal leukocytes were present in the stool , the furazolidone/ort-treated patients had a significantly higher percentage of clinical cures ( 79 % versus 54 % , p = 0.03 ) and an overall shorter duration of diarrhea ( 62.0 h versus 80.6 h , p = 0.055 ) at the end of 5 days of therapy than did the placebo/ort-treated group .
C0016855
furazolidone
C0011991
diarrhea